Literature DB >> 22172933

Relationship between circulating IGF-1 levels and traumatic brain injury-induced hippocampal damage and cognitive dysfunction in immature rats.

Durgul Ozdemir1, Basak Baykara, Ilkay Aksu, Muge Kiray, Ali Riza Sisman, Ferihan Cetin, Ayfer Dayi, Tugba Gurpinar, Nazan Uysal, M Nuri Arda.   

Abstract

It is well known that traumatic brain injury (TBI) induces the cognitive dysfunction resulting from hippocampal damage. In the present study, we aimed to assess whether the circulating IGF-I levels are associated with cognition and hippocampal damage in 7-day-old rat pups subjected to contusion injury. Hippocampal damage was examined by cresyl violet staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay. Spatial memory performance was assessed in the Morris water maze. Serum IGF-1 levels decreased in both early and late period of TBI. Decreased levels of serum IGF-1 were correlated with hippocampal neuron loss and spatial memory deficits. Circulating IGF-1 levels may be predictive of cognitive dysfunction resulted from hippocampal damage following traumatic injury in developing brain. Therapy strategies that increase circulating IGF-1 may be highly promising for preventing the unfavorable outcomes of traumatic damage in young children.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172933     DOI: 10.1016/j.neulet.2011.11.059

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

Review 1.  Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?

Authors:  Anthony E Kline; Jacob B Leary; Hannah L Radabaugh; Jeffrey P Cheng; Corina O Bondi
Journal:  Prog Neurobiol       Date:  2016-05-07       Impact factor: 11.685

Review 2.  A clinical and pathophysiological approach to traumatic brain injury-induced pituitary dysfunction.

Authors:  Sule Temizkan; Fahrettin Kelestimur
Journal:  Pituitary       Date:  2019-06       Impact factor: 4.107

3.  Microglial inhibitory effect of ginseng ameliorates cognitive deficits and neuroinflammation following traumatic head injury in rats.

Authors:  Anil Kumar; Puneet Rinwa; Hitesh Dhar
Journal:  Inflammopharmacology       Date:  2013-09-20       Impact factor: 4.473

4.  Blockage of the upregulation of voltage-gated sodium channel nav1.3 improves outcomes after experimental traumatic brain injury.

Authors:  Xian-Jian Huang; Wei-Ping Li; Yong Lin; Jun-Feng Feng; Feng Jia; Qing Mao; Ji-Yao Jiang
Journal:  J Neurotrauma       Date:  2013-12-06       Impact factor: 5.269

5.  The effects of repeat traumatic brain injury on the pituitary in adolescent rats.

Authors:  Tiffany Greco; David Hovda; Mayumi Prins
Journal:  J Neurotrauma       Date:  2013-10-08       Impact factor: 5.269

Review 6.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

7.  DA Negatively Regulates IGF-I Actions Implicated in Cognitive Function via Interaction of PSD95 and nNOS in Minimal Hepatic Encephalopathy.

Authors:  Saidan Ding; Weishan Zhuge; Xuebao Wang; Jianjing Yang; Yuanshao Lin; Chengde Wang; Jiangnan Hu; Qichuan Zhuge
Journal:  Front Cell Neurosci       Date:  2017-09-06       Impact factor: 5.505

Review 8.  Neuroendocrine Abnormalities Following Traumatic Brain Injury: An Important Contributor to Neuropsychiatric Sequelae.

Authors:  Amir M Molaie; Jamie Maguire
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-25       Impact factor: 5.555

9.  Sarcopenia, a neurogenic syndrome?

Authors:  Ping Kwan
Journal:  J Aging Res       Date:  2013-03-13

Review 10.  Role and Importance of IGF-1 in Traumatic Brain Injuries.

Authors:  Annunziato Mangiola; Vera Vigo; Carmelo Anile; Pasquale De Bonis; Giammaria Marziali; Giorgio Lofrese
Journal:  Biomed Res Int       Date:  2015-08-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.